KIYATEC

Medical research services related to predictive tests for patient benefit from anti-cancer drugs or combination of drugs; Pharmaceutical research services, namely, preclinical assessment of pharmaceutical drugs; Scientific and technological services, namely, research in the field of anti-cancer therapies using ex vivo assays; Medical testing services, namely, performing non-clinical assays and testing for medical research purposes in the field of anti-cancer therapies, not for diagnostic or treatment purposes; Providing medical and scientific research information in the field of clinical trials, assays, and assay development, and cancer; Laboratory research in the field of oncology

Medical clinical testing services for diagnostic or treatment purposes, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies; Medical services in the nature of personalized medicine services, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies